FORCE: Facing Our Risk of Cancer Empowered

10/14/2026

📢 BIG NEWS!

FORCE has expanded its educational resources to include gastric (stomach) cancer.

Why? Several hereditary cancer genes are associated with gastric cancer risk, making this an important issue for many members of our community. Our new resources cover genetic testing, screening, prevention, treatment, biomarkers and research opportunities.

Explore the new content and help us spread the word that no one should face hereditary cancer alone. https://ow.ly/IJgQ50ZxJXK

10/13/2026

🎙️ We’re proud to share this conversation featuring FORCE founder Sue Friedman on Young: Navigating Breast Cancer Together.

Thank you for inviting Sue to join the conversation and giving FORCE: Facing Our Risk of Cancer Empowered the opportunity to connect with listeners. 💙

🎧 Listen to the episode https://sites.libsyn.com/608540/young-navigating-breast-cancer-together-episode-6-force

In this episode, Katie and guest host Felicia talk with Sue, the founder of . They discuss FORCE’s mission and hereditary cancer. Hereditary cancers are specific cancers that are caused by inherited genetic mutations. FORCE works to support people and families affected by hereditary cancer. They o...

10/13/2026

Metastatic breast cancer research continues to move forward. 💙

A recent XRAY review of studies presented at ASCO 2026 found that people taking GLP-1 medications often had better breast cancer outcomes than similar people who were not taking these drugs. Researchers also reported improved survival among some people living with metastatic breast cancer.

While these findings are promising, they come from observational studies and do not prove that GLP-1 drugs directly improve cancer outcomes. More research is needed before these results can change medical care.

On Metastatic Breast Cancer Awareness Day, we're highlighting emerging research that may help shape the future of care for people living with MBC.

Read the XRAY review to learn what researchers found and what it could mean for you. 💙

10/12/2026

Hot flashes. Brain fog. Sleep changes. Big decisions.

For many people facing hereditary cancer risk, menopause is more than a life stage. It can be influenced by cancer treatment or by choices such as preventive o***y removal.

This National Menopause Month, we're sharing trusted resources to help you understand your options, including information on menopause, hormone replacement therapy and a decision checklist for o***y removal.

Knowledge is power. Explore the resources, start the conversation and find support for your next step. 💜https://ow.ly/9a7750ZWqoP

10/12/2026

The KATSIS-1 phase 3 clinical trial is investigating a potential treatment designed to block breast cancer cells from growing and surviving. Rather than being based on a specific test result, this treatment may work by interfering with how the cancer cells function. Learn more and see if you may qualify for participation.

Link: https://ow.ly/Hwzu50Zhnb8

This is a paid promotion.

Join us in the pursuit to change patients’ lives. Each and every person in a clinical trial plays a powerful role.

10/11/2026

BRCA1 and BRCA2 get a lot of headlines, but they aren't the only genes linked to hereditary breast cancer. Mutations in genes like ATM, CHEK2, PALB2, PTEN and others can also raise risk.

Whatever your mutation, you have a community. FORCE hosts virtual support meetings for people with genetic mutations that increase their risk of cancer.

Find a meeting: https://ow.ly/vGvw50ZSoTQ

10/11/2026

Ask the Experts: Updates in Breast Cancer

Join FORCE on Monday, October 26, 2026 at 6:00pm EDT for an in-depth and interactive discussion on the latest breast cancer research and clinical advances.

This live event will include interviews and a Q & A with our experts, highlighting what’s new, what remains the same, and areas of emerging research.

Our experts cover updates on the following topics:
🩵Genes linked to breast cancer
🩷Screening and prevention
💜Treatment
💙Clinical research

After the interviews, you can join a breakout group to ask your own questions of our experts.

Register today! https://ow.ly/XTLB50ZSUtL

10/10/2026

💗 October is Breast Cancer Awareness Month.

Did you know that about 5-10% of breast cancers are caused by an inherited genetic mutation? Mutations in genes such as BRCA1, BRCA2, PALB2, CHEK2, ATM, TP53 and others can increase the risk of breast cancer and other cancers.

Knowing your family health history and genetic risk can help you make informed decisions about screening, risk reduction and treatment. Genetic testing may also provide important information for family members who could be at risk.

This Breast Cancer Awareness Month, FORCE is proud to partner with Susan G. Komen, Know Your Lemons and the Breast Cancer Resource Center to raise awareness about hereditary breast cancer and the importance of knowing your risk.

💗 Knowledge is power. Family history and genetic testing can help save lives.



Susan G. Komen Know Your Lemons Foundation, Breast Cancer Resource Center

10/09/2026

When Marleah Dean Kruzel learned she carried an inherited BRCA2 mutation, she turned her personal experience into a mission to help others understand hereditary cancer risk and the power of genetic testing. In this powerful story, she shares how family history shaped her journey and why informed decision-making matters.

We're grateful to Marleah for shining a light on hereditary cancer risk, advocating for genetic testing, and for mentioning FORCE as a resource for individuals and families navigating these decisions. Thank you for helping more people access the information, support, and community they deserve. 💙

Read the article: USF researcher knew cancer ran in her family. Genetic testing told her why Marleah discusses her BRCA2 experience, advocates for genetic testing, and recommends FORCE as a resource for those facing hereditary cancer risk.

Read the article here: https://www.usf.edu/news/2026/usf-researcher-knew-cancer-ran-in-her-family-genetic-testing-told-her-why.aspx



Marleah Dean Kruzel

Marleah Dean Kruze was just a child when her mother was diagnosed with breast cancer. She’s since discovered that she carries an inherited BRCA2 mutation and is using her personal experience to help others understand hereditary cancer risk.

10/09/2026

Prostate Cancer Screening – Should you have to pay a copay?

African Americans and those with a family history of prostate cancer and/or certain genetic mutations are at increased risk of prostate cancer. For these individuals, prostate cancer screening is crucial. Unfortunately, the Affordable Care Act doesn’t require coverage of these screenings; many health plans do, but patients incur a copay. FORCE is working with its partners to pass laws that eliminate the out-of-pocket costs for these screenings. Does your state have a law that requires coverage? https://ow.ly/X7Em50YO2UV